Outcomes4Me Celebrated as One of Time's Best Inventions of 2025

Outcomes4Me Named One of Time’s Best Inventions of 2025

In a notable recognition of innovation in healthcare, Outcomes4Me has made its way onto Time's prestigious "Best Inventions of 2025" list. The announcement was made on October 9, 2025, marking a significant milestone for the Boston-based company that stands out as the first and only comprehensive, AI-driven patient empowerment platform tailored for cancer patients. This platform is revolutionizing the way individuals approach their cancer care journey—from diagnosis to long-term management.

Founded with a mission to bridge critical gaps in cancer treatment delivery, Outcomes4Me aims to empower patients by providing them with personalized, actionable information. Currently, the platform serves over 400,000 cancer patients globally, enabling them to navigate through their treatment plans with increased confidence.

Addressing the Gaps in Cancer Care

Dr. Maya R. Said, founder and CEO of Outcomes4Me, highlighted the urgent need for innovative solutions in the current healthcare landscape, where individuals diagnosed with cancer often face overwhelming challenges. "As breakthroughs in cancer treatment accelerate, critical gaps emerge. Patients often miss life-saving options while healthcare providers struggle with resource constraints," she explained. Outcomes4Me was created to mitigate these issues, offering a platform that delivers timely and relevant information, thereby enhancing the patient experience.

The platform integrates various functions, including clinical guidelines, genomics, symptom management, and clinical trial matching to provide a comprehensive support system to patients. This tailored approach allows cancer patients to actively participate in their treatment decisions and to manage side effects more effectively. By connecting patients to the right resources and healthcare teams promptly, Outcomes4Me actively works to ensure better health outcomes.

A Comprehensive Approach

Outcomes4Me operates on an enterprise model that monitors real-time signals to optimize next-best-action systems. This feature not only helps patients but also empowers life sciences companies to deliver the appropriate care efficiently. By monitoring clinical data and patient interactions, the platform plays a pivotal role in improving overall healthcare delivery.

Dr. Said noted that being recognized by Time for 'demystifying cancer care' underscores the importance of the company’s mission. “We are honored to be celebrated for our work in transforming the patient experience for those living with cancer,” she added.

Recognizing Innovation in Healthcare

Time's selection process for its Best Inventions list involved thorough evaluations by its editors and correspondents worldwide, focusing on originality, effectiveness, ambition, and impact. The year’s list showcases over 300 innovations that are reshaping our lives, particularly in emerging fields like healthcare and artificial intelligence.

In addition to this recognition, Outcomes4Me has recently expanded its influence by acquiring Europe's Mika app, further solidifying its position as the leading cancer platform worldwide. The company also made an impressive debut on the Inc. 5000 list of the fastest-growing private companies, landing at number 329, further exemplifying its rapid growth and significant impact in the healthcare sector.

With its innovative technology and a growing patient community, Outcomes4Me is not just a platform; it is a pioneering force in cancer care, guiding patients toward better health outcomes one step at a time. As a women-led organization composed of healthcare, oncology, and technology experts, Outcomes4Me is prepared to lead the charge in the evolution of cancer treatment, ensuring that patients worldwide have the information and support they need to make informed decisions about their care.

For those interested in learning more about the transformative potential of Outcomes4Me, further information can be found on their official website: Outcomes4Me.